Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
Methylation of specific CpG sites in the HPV16 L1 gene holds promise as a biomarker for cervical cancer progression. The gene locus at position 6367 has important features in the methylation pattern of cervical cancer, and high accuracy shown in diagnosis make it a potential biomarker for early diagnosis of cervical cancer.
Authors
- Sha Ji (ORCID: https://orcid.org/0009-0001-1924-8861)
- Nannan Ji
Institutions
- Shihezi University (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fonc.2025.1481621
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00